News

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that the United States (U.S.) ...
The US Food and Drug Administration (FDA) has approved Neuspera Medical’s integrated sacral neuromodulation (iSNM) system for ...
The FDA has approved Gilead Sciences' lenacapavir, sold under the name Yeztugo, as a twice-yearly injection for preventing ...
The US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a ...
Gilead Sciences, Inc. GILD obtained FDA approval for its twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, for the ...
The U.S. FDA approved Gilead Sciences' lenacapavir, under the brand name Yeztugo, for HIV prevention. This twice-yearly ...
The state's new law marks one of the largest government investments into psychedelics to date, with advocates citing the drug ...
While PrEP tablets are already prescribed around the world to prevent people from contracting HIV, experts in the US hope a newly approved jab could improve rates of protection.
Sanofi SNY and its partner, Regeneron REGN, announced that the FDA has approved their blockbuster medicine, Dupixent ...
Agappe Corporate Office COCHIN, KERALA, INDIA, June 20, 2025 /EINPresswire / -- Agappe Diagnostics Ltd is poised to pioneer a transformative c ...
TEL AVIV, Israel, June 18, 2025 /PRNewswire/ -- MedHub-AI, a global leader in AI-powered cardiovascular diagnostics, announced today that the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan ...